Przejdź do zawartości
Merck
Wszystkie zdjęcia(3)

Kluczowe dokumenty

HNS2MAG-95K

Millipore

MILLIPLEX® Human Neuroscience Magnetic Bead Panel 2 - Neuroscience Multiplex Assay

The analytes available for this multiplex kit are: Angiogenin, ApoE4, FABP3, Ferritin, Neurogranin, and TREM2.

Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych


About This Item

Kod UNSPSC:
12161503
eCl@ss:
32161000
NACRES:
NA.47

reaktywność gatunkowa

human

producent / nazwa handlowa

Milliplex®

assay range

accuracy: 124%
(Neurogranin)

accuracy: 84%
(FABP3)

accuracy: 85%
(ApoE4)

accuracy: 94%
(TREM2)

accuracy: 97%
(Angiogenin)

sensitivity: 11.0 pg/mL
(MinDC + 2SD; TREM2)

sensitivity: 14.3 pg/mL
(MinDC + 2SD; FABP3)

sensitivity: 162.8 pg/mL
(MinDC + 2SD; ApoE4)

sensitivity: 19.9 pg/mL
(MinDC + 2SD; Neurogranin)

sensitivity: 5.8 pg/mL
(MinDC + 2SD; Angiogenin)

sensitivity: 6.1 pg/mL
(MinDC + 2SD; Ferritin)

standard curve range: 15-50,000 pg/mL
(TREM2)

standard curve range: 2-10,000 pg/mL
(Angiogenin)

standard curve range: 24-100,000 pg/mL
(FABP3)

standard curve range: 244-1,000,000 pg/mL
(ApoE4)

standard curve range: 5-20,000 pg/mL
(Neurogranin)

standard curve range: 6-25,000 pg/mL
(Ferritin)

inter-assay cv: <10%
intra-assay cv: <5%
(Angiogenin)

inter-assay cv: <10%
intra-assay cv: <5%
(FABP3)

inter-assay cv: <10%
intra-assay cv: <5%
(TREM2)

inter-assay cv: <15%
intra-assay cv: <10%
(Ferritin)

inter-assay cv: <15%
intra-assay cv: <10%
(Neurogranin)

inter-assay cv: <15%
intra-assay cv: <5%
(ApoE4)

metody

multiplexing: suitable

metoda wykrywania

fluorometric (Luminex xMAP)

Opis ogólny

Monitoring protein biomarkers in cerebrospinal fluid (CSF) of patients with neurological disorders has been highly beneficial to understanding disease progression. While several CSF biomarkers can reproducibly distinguish normal and diseased samples, CSF is a difficult biological fluid to obtain in research studies. The need for blood-based biomarkers of AD has driven a continuous search for novel candidates. This configurable multiplex immunoassay quantitatively measures six proteins present in both human CSF and blood plasma/serum that are involved in neurological disease. Cell/tissue culture samples may also be used in the panel.

MILLIPLEX® Human Neuroscience Bead Panel 2 is a 6-plex kit to be used for the simultaneous quantification of any or all of the following analytes in cerebrospinal fluid (CSF), serum/plasma and cell/tissue culture supernatants for homogenates: Angiogenin, ApoE4, FABP3, Ferritin, Neurogranin, TREM2.

Panel Type: Neuroscience

Specyficzność

Cross Reactivty
Cross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible. There is <5% cross-reactivity from ApoE2 and ApoE3 recombinant proteins on the ApoE4 beads.

Zastosowanie

  • Analytes: Angiogenin, ApoE4, FABP3, Ferritin, Neurogranin, TREM2
  • Recommended Sample type: Plasma, Serum, CSF, Cell/Tissue culture supernatant
  • For Plasma/Serum a 1:10 dilution is recommended for the optimal detection of the analytes FABP3, Ferritin, Neurogranin and TREM2.
  • For Plasma/Serum a 1:200 dilution for ApoE4 and Angiogenin is recommended.
  • Because the sample dilutions differ for Plasma/Serum samples ApoE4 and Angiogenin cannot be plexed in the same assay as FABP3, Ferritin, Neurogranin and TREM2.
  • CSF samples require a 1:10 dilution and so may all be plexed together
  • Cell/Tissue culture supernatants or homogenates may be used neat or diluted in appropriate control medium.
  • Bead diluent must be present in order to detect Angiogenin. (Biotinylated-Angiogenin detection antibody is included in the bead diluent.)
  • Research Category: Neuroscience

Cechy i korzyści

Design your multiplex kit by choosing available analytes within this panel.

Opakowanie

Everything you need in a single kit.

Przechowywanie i stabilność

Recommended storage for kit components is 2 - 8°C.

Informacje prawne

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

Oświadczenie o zrzeczeniu się odpowiedzialności

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Ta strona może zawierać tekst przetłumaczony maszynowo.

Piktogramy

Skull and crossbonesEnvironment

Hasło ostrzegawcze

Danger

Zwroty wskazujące rodzaj zagrożenia

Klasyfikacja zagrożeń

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Sens. 1

Kod klasy składowania

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects


Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Maciej Dulewicz et al.
Journal of clinical medicine, 10(19) (2021-10-14)
Synaptic loss and dysfunction are one of the earliest signs of neurodegeneration associated with cognitive decline in Alzheimer's disease (AD). It seems that by assessing proteins related to synapses, one may reflect their dysfunction and improve the understanding of neurobiological
Frederic Brosseron et al.
Journal of neurochemistry, 157(6), 2210-2224 (2020-09-08)
There is growing evidence that promising biomarkers of inflammation in Alzheimer´s disease (AD) and other neurodegenerative diseases correlate strongest to levels of tau or neurofilament, indicating an inflammatory response to neuronal damage or death. To test this hypothesis, we investigated

Powiązane treści

Learn how to integrate multiplex and high sensitivity immunoassay technology to further neuroscience research with MILLIPLEX® multiplex and Single Molecule Counting (SMC®) high sensitivity immunoassay detection of Alzheimer’s disease (AD) biomarkers in human cerebrospinal fluid, plasma, and serum samples.

Usprawnij badania dzięki końcówkom do multipleksowania MILLIPLEX®, wskazówkom branżowym i jednodniowym testom w ograniczonym czasie laboratoryjnym.

Uncover tips and tricks to multiplexing in this guide from the experts. Learn how you can enhance the power of your research with MILLIPLEX® multiplexing, including industry guidance for immunoassays, multiplexing tips, one-day MILLIPLEX® multiplex assays for limited lab time, and more.

Odkryj zalety testów multipleksowych MILLIPLEX®, opartych na technologii testów multipleksowych Luminex® xMAP®, które zapewniają spójne, wysokiej jakości wyniki i zobacz, w jaki sposób te multipleksowe testy biomarkerów Luminex® są wykorzystywane do postępu badań.

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej